On May 15, the National Medical Products Administration approved JumpCan Pharmaceutical's exclusive dosage form product, Pudilan Xiaoyan Oral Liquid, as the first Secondary Protected TCM variety. This achievement not only represents full affirmation of the product's clinical value, quality standards, and market position, but also marks an important milestone in JumpCan Pharmaceutical's TCM inheritance and innovation.

The Protected TCM Variety scheme is an exclusive protection system established under the State Council's Regulations on the Protection of Traditional Chinese Medicine Varieties. It encourages enterprises to deeply cultivate classic formulas and innovate TCM R&D, and promotes the high-quality development of the TCM industry. Tiered administrative protection is implemented for TCM varieties with stable quality, definitive efficacy, and outstanding clinical value; during the protection period, other enterprises may not produce the same variety without authorization, safeguarding the legitimate rights and interests of TCM R&D enterprises.

As a classic representative of heat-clearing and detoxifying Chinese patent medicines that has been on the market for over twenty years, Pudilan Xiaoyan Oral Liquid's formulation originates from traditional proven prescriptions and has been refined through modern processes. Its efficacy has been verified through long-term clinical practice and multiple evidence-based studies. Approval as a protected TCM variety signifies that its core formula, processing techniques, and market exclusivity have received authoritative national recognition.

From the modernization of classic formulas to the cultivation of exclusive varieties; from innovative R&D of pediatric dosage forms to quality control throughout the entire TCM industrial chain — as a deep practitioner in the Chinese patent medicine field, JumpCan Pharmaceutical has always been grounded in clinical needs, practicing the concept of TCM inheritance, integrity, innovation and development, driving the inheritance and development of TCM through scientific and technological innovation, upholding quality standards to safeguard public health, and promoting the deep integration of traditional TCM with modern science and technology. In the future, JumpCan Pharmaceutical will continue to scale up TCM R&D investment, focus on unmet clinical medication needs, continuously introduce more high-quality innovative TCM drugs, provide patients with diverse treatment options, and contribute more JumpCan strength to safeguarding public health.